Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June 9th in Vancouver, British Columbia, Canada.

 Society of Nuclear Medicine and Molecular Imaging, Patient Program, June 9, 2013, Vancouver, Canada

SNMMI has long been committed to supporting patients, partnering with patient advocacy organizations on issues of mutual interest and priority, and providing educational programs to help patients understand molecular imaging and its role in both diagnostic and therapeutic settings. For the third year, the SNMMI Patient Advocacy Advisory Board has developed a “Patient Program” to address key topics of interest to the patient and patient advocacy community. This program provides a unique opportunity to network with passionate advocates and leading experts in neuroendocrine tumors (NETs), lymphoma disease, and dementia.

Josh Mailman, Chair, SNMMI Patient Advocacy Advisory Board

Josh Mailman, Chair, SNMMI Patient Advocacy Advisory Board

According to Josh Mailman, “The SNMMI Patient Advocacy Advisory Board is dedicated to educating patients about nuclear medicine and molecular imaging so that they can make the best healthcare decisions for their individual needs. “  The program for the day includes a keynote speech by a patient on his journey with nuclear medicine and molecular imaging, general education sessions, and breakout sessions on the latest advances for NETs, lymphoma, and dementia.  A guided tour of the exhibit hall will give participants a first-hand look at the science and technology behind nuclear medicine and molecular imaging and therapy.

In the area of neuroendocrine tumors, the breakout session will feature the following:

  • Jackie Herman, President, CNETS Canada

    Jackie Herman, CNETS Canada

    • Introduction and Welcome from Carcinoid Neuroendocrine Tumour Society Canada

Jackie Herman, President

  • Patient Perspective – John Martin
  • Theranostics – New Perspectives on Personalized Care for NETs

Richard P. Baum, MD, PhD

Richard Baum, MD

Richard Baum, MD, PhD

  • Approaches to Imaging Neuroendocrine Tumors DOTA-NOC
Alexander (Sand) McEwan, MD

Alexander (Sandy) McEwan, MD

Alexander (Sandy) McEwan, MD

  • Updates on Imaging in BC for NETs Patients

Hagen Kennecke, MD of BC Cancer Agency

  • Panel Q&A
  • Focus Group – What are the barriers to adoptions of nuclear imaging and treatment for NETs
  • Speed  Networking

For further information about the SNMMI Patient Education Day and to register, click here: http://www.discovermi.org.

Print Friendly, PDF & Email